Monoclonal antibodies have shown tremendous success in cancer treatment; however, humanization for clinical applications is expensive and not straightforward. Now, molecularly imprinted polymer nanogels have been developed that can block cell-surface proteins and disrupt tumour spheroids.
Plastic antibodies for cancer therapy?
Bossi
2020-01-01
Abstract
Monoclonal antibodies have shown tremendous success in cancer treatment; however, humanization for clinical applications is expensive and not straightforward. Now, molecularly imprinted polymer nanogels have been developed that can block cell-surface proteins and disrupt tumour spheroids.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
41557_2019_415_Author.pdf
non disponibili
Tipologia:
Documento in Pre-print
Licenza:
Accesso ristretto
Dimensione
1.49 MB
Formato
Adobe PDF
|
1.49 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
